IBOV 169,295.41 ▼ 1.83% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL5.78▼ 0.13% USD/MXN18.50▼ 0.10% USD/CLP997.53▲ 0.27% USD/COP3,329▲ 0.31% USD/PEN3.41▲ 0.10% USD/ARS1,550▲ 0.37% USD/UYU40.61▲ 3.40% USD/PYG6,186▲ 2.79% USD/BOB 11.59 — 0.00% USD/DOP60.36▲ 2.08% USD/CRC442.56▲ 1.76% USD/GTQ7.64▲ 3.16% USD/HNL26.90▼ 0.05% USD/NIO36.62▲ 2.50% USD/VES913.46▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.99▲ 2.99% USD/TTD6.72▲ 1.97% EUR/BRL6.35▲ 1.80% BRENT 92.63 ▲ 0.21% WTI 85.82 ▲ 0.12% IRON ORE 161.91 — — COPPER 5.96 ▼ 0.56% GOLD 3,865 ▲ 0.32% SILVER 47.29 ▲ 1.08% SOY 1,229 ▼ 0.04% CORN 451.25 ▲ 0.56% WHEAT 607.50 ▲ 3.49% COFFEE 283.00 ▲ 0.82% SUGAR 18.06 ▼ 0.22% ORANGE JUICE 135.75 ▼ 0.40% COTTON 81.01 ▲ 5.21% COCOA 5,061 ▼ 1.13% BEEF 220.50 ▼ 0.07% CATTLE 337.25 ▼ 0.52% LITHIUM 56.84 ▼ 3.27% PETR4 44.02 ▼ 2.83% VALE3 60.70 ▼ 4.41% ITUB4 41.30 ▼ 2.29% BBDC4 14.23 ▼ 2.00% ABEV3 15.87 ▲ 0.51% BBAS3 14.95 ▼ 0.99% B3SA3 14.81 ▼ 0.54% WEGE3 50.40 ▼ 1.77% PRIO3 62.63 ▼ 1.06% SUZB3 55.50 ▲ 1.33% RENT3 29.31 ▼ 2.53% AZZA3 16.14 ▲ 1.45% CSAN3 3.09 ▼ 0.32% RAIZ4 19.11 ▼ 4.45% PCAR3 2.60 ▲ 1.56% GMAT3 4.13 ▼ 2.82% PSSA3 45.54 ▼ 1.87% CVCB3 0.79 ▼ 4.82% POSI3 3.10 ▼ 1.59% SLCE3 17.85 ▼ 2.35% NATU3 4.90 ▼ 4.48% BRKM5 2.84 ▼ 5.96% RANI3 8.19 ▲ 0.12% CSNA3 3.68 ▼ 1.08% IBOV 169,295.41 ▼ 1.83% IPC MEX 71,204.98 ▼ 0.84% MERVAL 2,848,945 — — USD/BRL 5.78 ▼ 0.10% USD/MXN 18.50 ▼ 0.07% USD/CLP 997.53 ▲ 0.27% USD/COP 3,315 ▼ 0.09% USD/PEN 3.41 ▲ 0.10% USD/ARS 1,550 ▼ 0.02% USD/UYU 40.61 ▲ 3.40% USD/PYG 6,186 ▼ 0.16% USD/BOB 11.59 — 0.00% USD/DOP 60.36 ▲ 2.08% USD/CRC 442.56 ▼ 0.04% USD/GTQ 7.64 ▼ 0.05% USD/HNL 26.90 ▲ 3.00% USD/NIO 36.62 ▲ 2.50% USD/VES 913.46 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.99 ▲ 2.99% USD/TTD 6.72 ▲ 1.97% EUR/BRL 6.36 ▲ 1.91% BRENT 92.63 ▲ 0.21% WTI 85.82 ▲ 0.12% IRON ORE 161.91 — — COPPER 5.96 ▼ 0.56% GOLD 3,865 ▲ 0.32% SILVER 47.29 ▲ 1.08% SOY 1,229 ▼ 0.04% CORN 451.25 ▲ 0.56% WHEAT 607.50 ▲ 3.49% COFFEE 283.00 ▲ 0.82% SUGAR 18.06 ▼ 0.22% ORANGE JUICE 135.75 ▼ 0.40% COTTON 81.01 ▲ 5.21% COCOA 5,061 ▼ 1.13% BEEF 220.50 ▼ 0.07% CATTLE 337.25 ▼ 0.52% LITHIUM 56.84 ▼ 3.27% PETR4 44.02 ▼ 2.83% VALE3 60.70 ▼ 4.41% ITUB4 41.30 ▼ 2.29% BBDC4 14.23 ▼ 2.00% ABEV3 15.87 ▲ 0.51% BBAS3 14.95 ▼ 0.99% B3SA3 14.81 ▼ 0.54% WEGE3 50.40 ▼ 1.77% PRIO3 62.63 ▼ 1.06% SUZB3 55.50 ▲ 1.33% RENT3 29.31 ▼ 2.53% AZZA3 16.14 ▲ 1.45% CSAN3 3.09 ▼ 0.32% RAIZ4 19.11 ▼ 4.45% PCAR3 2.60 ▲ 1.56% GMAT3 4.13 ▼ 2.82% PSSA3 45.54 ▼ 1.87% CVCB3 0.79 ▼ 4.82% POSI3 3.10 ▼ 1.59% SLCE3 17.85 ▼ 2.35% NATU3 4.90 ▼ 4.48% BRKM5 2.84 ▼ 5.96% RANI3 8.19 ▲ 0.12% CSNA3 3.68 ▼ 1.08%
since 2009
Tuesday, November 17, 2026

Covid-19 Brazil

CoronaVac is safe and induces immune response in adolescents and children – study

By · · 2 min read

RIO DE JANEIRO, BRAZIL – Chinese Sinovac Biotech’s CoronaVac, the Covid-19 vaccine filled in Brazil by the Butantan Institute, is safe and induces immune response in adolescents and children aged 3 to 17, showed a study published on Monday, June 28.

According to Butantan, the study’s findings published by The Lancet were the result of phase 1 and 2 clinical trials with 552 participants between October and December 2020 conducted in the Chinese province of Hebei.

CoronaVac is safe and induces immune response in adolescents and children – study
Study says the ConoraVac is safe and induces immune response in adolescents and children aged 3 to 17.
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

The study was conducted by Sinovac in partnership with Chinese institutions.

The neutralizing antibody seroconversion rate, which indicates the production of antibodies against the coronavirus, reached over 96% after 28 days of the two dose vaccination, the institute said, adding that adverse reactions observed were mild or moderate.

“The data, therefore, indicate an optimal safety profile and good neutralizing antibody titers induced by the immunizer, which supports a two-dose vaccination scheme for further studies in children and adolescents,” the Butantan said in a statement.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “US rule would require licences for AI chips to Brazil”

According to the Butantan, the data related to the CoronaVac study in children and adolescents have been forwarded to the Brazilian Health Regulatory Agency (ANVISA).

“The results show that the vaccine is safe also for children and youths. With the research progress it will very soon be possible to certify the CoronaVac’s efficacy in this specific population,” said Butantan president Dimas Covas in the release.

So far, only the Pfizer vaccine has been approved for use in people under 18 years of age in Brazil, authorized for adolescents over 12.

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.